BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12221935)

  • 1. Elimination of Pasteurella pneumotropica from a contaminated mouse colony by oral administration of Enrofloxacin.
    Ueno Y; Shimizu R; Nozu R; Takahashi S; Yamamoto M; Sugiyama F; Takakura A; Itoh T; Yagami K
    Exp Anim; 2002 Jul; 51(4):401-5. PubMed ID: 12221935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of various therapeutic regimens in eliminating Pasteurella pneumotropica from the mouse.
    Goelz MF; Thigpen JE; Mahler J; Rogers WP; Locklear J; Weigler BJ; Forsythe DB
    Lab Anim Sci; 1996 Jun; 46(3):280-5. PubMed ID: 8799933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of Pasteurella pneumotropica from a mouse barrier facility by using a modified enrofloxacin treatment regimen.
    Towne JW; Wagner AM; Griffin KJ; Buntzman AS; Frelinger JA; Besselsen DG
    J Am Assoc Lab Anim Sci; 2014 Sep; 53(5):517-22. PubMed ID: 25255075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy.
    Macy JD; Weir EC; Compton SR; Shlomchik MJ; Brownstein DG
    Comp Med; 2000 Feb; 50(1):49-55. PubMed ID: 10987669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An outbreak of Pasteurella pneumotropica in genetically modified mice: treatment and elimination.
    Matsumiya LC; Lavoie C
    Contemp Top Lab Anim Sci; 2003 Mar; 42(2):26-8. PubMed ID: 19757621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro susceptibility of rodent isolates of Pseudomonas aeruginosa and Pasteurella pneumotropica to enrofloxacin.
    Sasaki H; Kawamoto E; Kunita S; Yagami K
    J Vet Diagn Invest; 2007 Sep; 19(5):557-60. PubMed ID: 17823403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of Pasteurella multocida-free rabbit litters by enrofloxacin treatment.
    Suckow MA; Martin BJ; Bowersock TL; Douglas FA
    Vet Microbiol; 1996 Jul; 51(1-2):161-8. PubMed ID: 8828132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of enrofloxacin in the treatment of respiratory pasteurellosis in rabbits.
    Broome RL; Brooks DL
    Lab Anim Sci; 1991 Dec; 41(6):572-6. PubMed ID: 1667200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of enrofloxacin after single-dose oral and intravenous administration in the American alligator (Alligator mississippiensis).
    Helmick KE; Papich MG; Vliet KA; Bennett RA; Jacobson ER
    J Zoo Wildl Med; 2004 Sep; 35(3):333-40. PubMed ID: 15526888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the [Pasteurella] pneumotropica complex to Rodentibacter spp.: an update on [Pasteurella] pneumotropica.
    Benga L; Sager M; Christensen H
    Vet Microbiol; 2018 Apr; 217():121-134. PubMed ID: 29615244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of orally administered enrofloxacin in adult horses: a pilot study.
    Giguère S; Sweeney RW; Habecker PL; Lucas J; Richardson DW
    J Vet Pharmacol Ther; 1999 Oct; 22(5):343-7. PubMed ID: 10597539
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo activity of orally administered antibiotics and chemotherapeutics against acute septicaemic pasteurellosis in rabbits.
    Okerman L; Devriese LA; Gevaert D; Uyttebroek E; Haesebrouck F
    Lab Anim; 1990 Oct; 24(4):341-4. PubMed ID: 2270044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin.
    Prescott JF; Yielding KM
    Can J Vet Res; 1990 Jan; 54(1):195-7. PubMed ID: 2306672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrofloxacin serum bioactivity in bottlenose dolphins, Tursiops truncatus, following oral administration of 5 mg/kg in whole fish.
    Linnehan RM; Ulrich RW; Ridgway S
    J Vet Pharmacol Ther; 1999 Jun; 22(3):170-3. PubMed ID: 10447827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses.
    Bertone AL; Tremaine WH; Macoris DG; Simmons EJ; Ewert KM; Herr LG; Weisbrode SE
    J Am Vet Med Assoc; 2000 Nov; 217(10):1514-21. PubMed ID: 11128543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli.
    Trott DJ; Filippich LJ; Bensink JC; Downs MT; McKenzie SE; Townsend KM; Moss SM; Chin JJ
    J Med Microbiol; 2004 May; 53(Pt 5):439-443. PubMed ID: 15096555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs.
    Walker RD; Stein GE; Hauptman JG; MacDonald KH
    Am J Vet Res; 1992 Dec; 53(12):2315-9. PubMed ID: 1335707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of single-dose oral enrofloxacin in the horse.
    Langston VC; Sedrish S; Boothe DM
    J Vet Pharmacol Ther; 1996 Aug; 19(4):316-9. PubMed ID: 8866463
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategic administration of enrofloxacin in poultry to achieve higher maximal serum concentrations.
    Sumano LH; Gutierrez OL; Zamora QM
    Vet J; 2003 Mar; 165(2):143-8. PubMed ID: 12573603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of enrofloxacin in African grey parrots treated with medicated water.
    Flammer K; Aucoin DP; Whitt DA; Prus SA
    Avian Dis; 1990; 34(4):1017-22. PubMed ID: 2282007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.